Stock Track | Neogen Plunges 6.43% in Pre-Market as Q3 Loss Widens, Revenue Declines

Stock Track04-09 19:26

Neogen Corp's stock plummeted 6.43% in pre-market trading following the release of its fiscal third-quarter 2026 financial results, which revealed a widening net loss and declining revenue.

The company reported a net loss of $17 million for the quarter, compared to a smaller loss in the year-ago period. Revenue fell 4.4% to $211.2 million, with the Animal Safety segment experiencing a sharp 20.1% sales decline to $54.5 million due to issues with third-party suppliers.

While Neogen raised its full-year revenue outlook to $857-$860 million and maintained its adjusted EBITDA guidance of approximately $175 million, investors reacted negatively to the weaker-than-expected quarterly performance and the significant drop in Animal Safety sales.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment